jatkovaiheeseen, jossa Trudexaa annettiin 40 mg joka toinen viikko 60 kuukauden ajan. ###>Thereafter, patients enrolled in an open-label extension phase in which 40 mg of Trudexa was administered every other week up to 60 months. lP